...incorporate MME thresholds from the CDC. However, those state-level guidelines might be adjusted when the CDC implements updated Guideline. A proposed draft of updated Guideline was published in the Federal...
...incorporate MME thresholds from the CDC. However, those state-level guidelines might be adjusted when the CDC implements updated Guideline. A proposed draft of updated Guideline was published in the Federal...
...of an evidence-based drug formulary for workers’ compensation claims. The bill prohibits workers’ compensation and occupational disease compensation reimbursements for drugs specified as “not recommended” in the Official Disability Guidelines...
...is that the company would cease to operate in its current form and would instead emerge from bankruptcy as a public benefit company (PBC) owned by a trust or similar...
...in per-fill price increased 40.4% overall. While cancer is not the most common condition found in workers’ comp claims, it is prevalent enough that drug trends impacting cancer can make...
...the most recent addition to a growing number of states expanding cancer coverage for firefighters in workers’ comp. In April, Montana Senate Bill 160 was signed into law, expanding workers’ comp...
Those previously infected by coronavirus may face long-term health complications, potentially complicating workers' comp claims...
After a decade of combatting opioid abuse and addiction among injured worker patients, workers’ compensation payers are finally seeing a significant reduction in opioid prescriptions and costs. Visit RxInformer online...
The Workers’ Compensation Research Institute (WCRI) published the CompScope™ Benchmarks, 24th Edition, a series of 14 reports that measure the performance of 17 state workers’ comp systems from 2017-2022, with...
...PharmD, was featured in WorkCompWire’s Leaders Speak Series, discussing clinical trends in workers’ comp, including changing populations, shifts in chronic pain drug therapy, and comorbidities. Read the article in full online at WorkCompWire....
